Search results for "Parenteral"

showing 10 items of 102 documents

Verwertbarkeit verschiedener Cysteinderivate bei langfristiger parenteraler Ernährung

1989

Utilization of cysteine derivatives for parenteral nutrition was established by means of nitrogen balance of growing rats. N,N-bis-acetylcystine and bisacetyl-glycyl-cystine were not utilized as substrates. N-acetylcysteine, glutathione disulfide, and L-thiazolidine-(4)-carboxylic acid gave evidence as suitable cysteine sources for parenteral nutrition.

Nitrogen balancechemistry.chemical_compoundParenteral nutritionBiochemistryChemistryMedicine (miscellaneous)Glutathione disulfideBiochemistryNitrogen cycleFood ScienceCysteineZeitschrift für Ernährungswissenschaft
researchProduct

Stability of parenteral nutrition admixtures containing organic phosphates

1995

The use of organic phosphates to avoid calcium phosphate precipitation in parenteral nutrition mixtures has been proposed. The purpose of this study was to evaluate the stability of total parenteral nutrition admixtures containing glucose-1-phosphate or glycerol phosphate as the phosphate source over 3 days. Three parenteral nutrition admixtures, each containing glucose-1-phosphate (30.0 mmol), glycerol phosphate (31.4 mmol) or inorganic phosphate (30.0 mmol), and their corresponding aqueous phases were prepared in 3-L ethylene vinyl acetate plastic bags and infusion bottles, and stored at 5 +/- 1 degrees C or 22 +/- 3 degrees C without light protection. Physical stability analysis and samp…

Nutrition and DieteticsAqueous solutionChromatographybusiness.industryPrecipitation (chemistry)Ethylene-vinyl acetateCritical Care and Intensive Care MedicinePhosphatechemistry.chemical_compoundCreamingParenteral nutritionBiochemistrychemistryDynamic light scatteringEmulsionMedicinebusinessClinical Nutrition
researchProduct

Organic phosphates in parenteral nutrition: Pouring fresh water into an old bucket

1996

Nutrition and DieteticsParenteral nutritionAnimal scienceOrganic phosphatesFresh waterbusiness.industryEndocrinology Diabetes and MetabolismEnvironmental chemistryMedicinebusinessFat emulsionInfant newbornNutrition
researchProduct

Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.

2014

Objective To analyze the feasibility of laparoscopic/robotic secondary cytoreductive surgery and hyperthermic intraperitoneal intra-operative chemotherapy (SCS + HIPEC) in a retrospective series of isolated platinum sensitive recurrent ovarian cancer. Methods We retrospectively evaluated a consecutive series of ovarian cancer patients with isolated platinum sensitive relapse. Isolated relapse was defined as the presence of a single nodule, in a single anatomic site. In all cases the presence of isolated relapse was assessed at pre-operative FDG-PET/CT scan, and confirmed with staging laparoscopy performed immediately before SCS + HIPEC. Results 84 women with platinum sensitive relapse recei…

OVARIAN CANEROrganoplatinum Compoundsmedicine.medical_treatmentdrug therapy/pathology/surgery/therapyCarcinoma Ovarian EpithelialMultimodal ImagingCohort StudiesObstetrics and gynaecologyNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsInfusions ParenteralNeoplasms Glandular and EpithelialLaparoscopyadministration /&/ dosageTomographyRandomized Controlled Trials as TopicOvarian Neoplasmsmedicine.diagnostic_testObstetrics and GynecologyGlandular and EpithelialMiddle AgedDebulkingCombined Modality TherapyIsolated platinum sensitive relapseX-Ray ComputedOxaliplatinPhase III as TopicOncologyFemalediagnostic usemedicine.drugmedicine.medical_specialtyInfusionsAged Antineoplastic Combined Chemotherapy Protocols; administration /&/ dosage Cisplatin; administration /&/ dosage Clinical Trials; Phase II as Topic Clinical Trials; Phase III as Topic Cohort Studies Combined Modality Therapy Female Fluorodeoxyglucose F18; diagnostic use Humans Hyperthermia; Induced; methods Infusions; Parenteral Middle Aged Minimally Invasive Surgical Procedures Multimodal Imaging Neoplasms; Glandular and Epithelial; drug therapy/pathology/surgery/therapy Organoplatinum Compounds; administration /&/ dosage Ovarian Neoplasms; drug therapy/pathology/surgery/therapy Positron-Emission Tomography Radiopharmaceuticals; diagnostic use Randomized Controlled Trials as Topic Retrospective Studies Tomography; X-Ray Computed ocal; pathologyocalmethodsClinical Trials Phase II as TopicMinimally invasive surgeryOvarian cancerFluorodeoxyglucose F18ParenteralmedicineHumansMinimally Invasive Surgical ProceduresClinical TrialsHyperthermiaAgedRetrospective StudiesCisplatinChemotherapySeries (stratigraphy)HIPECbusiness.industryPhase II as TopicInducedHyperthermia Inducedmedicine.diseaseOxaliplatinSurgeryRoboticSettore MED/40 - GINECOLOGIA E OSTETRICIAClinical Trials Phase III as TopicPositron-Emission TomographyLaparoscopypathologyNeoplasm Recurrence LocalCisplatinRadiopharmaceuticalsbusinessOvarian cancerTomography X-Ray Computed
researchProduct

Suitability of non-glucose-carbohydrates for parenteral nutrition

1975

Postoperative parenteral nutrition can only be optimally effective if the characteristics of post-traumatic metabolism are taken into account. Two main possibilities are discussed for the carbohydrate component of parenteral nutrition during this phase: glucose with high doses of insulin or non-glucose carbohydrates (sugar substitutes) possibly in a suitable combination with glucose. The risks as well as the technical and organisational problems involved in the use of them are discussed and the authors prefer the second of the two alternatives. Possible side effects of non-glucose carbohydrates are pointed out and it is shown how these can be avoided by observing dose guidelines. So far a c…

Parenteral Nutritionmedicine.medical_treatmentBlood sugarPhysiologyFructoseCarbohydrate metabolismCritical Care and Intensive Care MedicineXylitolElectrolyteschemistry.chemical_compoundPregnancyDietary CarbohydratesmedicineHumansSugarXylitolOxalatesAdenine Nucleotidesbusiness.industryInsulinProteinsBilirubinGeneral MedicineMetabolismCarbohydrateLipid MetabolismUric AcidGlucoseParenteral nutritionBiochemistrychemistryLactatesFemaleParenteral Nutrition TotalbusinessEuropean Journal of Intensive Care Medicine
researchProduct

DEFECTIVE JEJUNAL BRUSH BORDER Na+/H+ EXCHANGE IN LETHAL FAMILIAN PROTRACTED DIARRHOEA

1989

The clinical spectrum of disease associated with the recently described defect in jejunal brush border membrane (BBM) Na+/H+ exchange remains poorly defined. We describe a further, lethal case of protracted diarrhoea in a child from a family in whom 2 previous siblings died of protracted diarrhoea at 2 and 11 months. The patient, a boy, was born at term weighing 2.9 kg and was admitted at 6d with profuse watery diarrhoea, severe dehydration and metabolic acidosis. Parenteral nutrition was started but the diarrhoea persisted, and he developed severe necrotising enterocolitis requiring an ileostomy. A high-output secretory diarrhoea persisted during nil by mouth (ileostomy fluid mmol/l: Na+ 1…

Pathologymedicine.medical_specialtyBrush borderbusiness.industryGlucose uptakemedicine.medical_treatmentMetabolic acidosismedicine.diseaseGastroenterologyIleostomyParenteral nutritionInternal medicinePediatrics Perinatology and Child HealthmedicineJejunal biopsyProtracted diarrhoeabusinessGastrointestinal functionPediatric Research
researchProduct

Bone mineral metabolism in the micropremie

2000

Environmental factors, nutritional supplies, hormonal status, diseases, and treatments appear to affect postnatal skeletal growth and mineralization in VLBW infants. Compared with their term counterparts, ELBW infants are at risk of postnatal growth deficiency and osteopenia at the time of hospital discharge. From recent data, DXA is becoming one of the reference techniques to evaluate mineral status, whole-body composition, and effects of dietary manipulations on weight gain composition and mineral accretion in preterm infants. Weight gain and length increases need to be evaluated carefully during the first weeks of life, in the intensive care unit and out of it, in the step down unit. Nut…

Peak bone massParenteral NutritionPediatricsmedicine.medical_specialtyBone mineral metabolismWeight Gainlaw.inventionCalcification PhysiologicEnteral NutritionlawInternal medicinemedicineHumansInfant Very Low Birth WeightInfant Nutritional Physiological PhenomenaInfant Nutritional Physiological PhenomenaMineralsBone Developmentbusiness.industryInfant NewbornObstetrics and Gynecologymedicine.diseaseIntensive care unitOsteopeniaEndocrinologyParenteral nutritionPediatrics Perinatology and Child Healthmedicine.symptomLinear growthbusinessWeight gainInfant Premature
researchProduct

Factors predicting distress among parents/caregivers of children with neurological disease and home enteral nutrition

2013

Background & aims Caregivers of children with chronic diseases included in a home enteral nutrition (HEN) programme are at risk of experiencing a feeling of burden, high level of anxiety and psychological distress. The aims of this study were: first, to examine the prevalence of symptoms of anxiety–depression in caregivers of children with neurological diseases requiring HEN by gastrostomy tube (GT); second, to compare the characteristics of caregivers with high or low risk of exhibiting symptoms of anxiety–depression; and third, to investigate possible associations to child disease severity and nutrition support mode. Methods A cross-sectional observational study was performed in 58 caregi…

Pediatricsmedicine.medical_specialtybusiness.industryCross-sectional studyPublic Health Environmental and Occupational HealthDiseaseAnthropometryDistressParenteral nutritionPediatrics Perinatology and Child HealthDevelopmental and Educational PsychologyMedicineAnxietyObservational studymedicine.symptombusinessPsychiatryDepression (differential diagnoses)Child: Care, Health and Development
researchProduct

In-use physicochemical and microbiological stability of biological parenteral products

2015

Pharmaceutical scientists in the biotechnology industry have traditionally focused on achieving acceptable shelf lives of drug products in their original, unopened product unit configuration (e.g., two years stored at 2–8 °C). However, it is now clear that stability considerations extend beyond

PharmacologyBiological ProductsBacteriabusiness.industryChemistry PharmaceuticalDrug CompoundingHealth PolicyProteinsBiotechnologyPharmaceutical SolutionsDrug StabilityHumansInfusions ParenteralBusinessBiochemical engineeringProduct (category theory)Drug ContaminationDrug PackagingBiotechnology industryAmerican Journal of Health-System Pharmacy
researchProduct

LA NUTRIZIONE PARENTERALE e L'INTESTINO RESIDUO: quale relazione nel decorso dei pazienti con Sindrome da Intestino Corto? Valutazione da una Casisti…

2004

In età pediatrica la Sindrome da INtestino Corto (SIC), il più delle volte conseguenza di un intervento chirurgico di resezione intestinale massiva, è la più frequente causa di Insufficienza Intestinale (ID). L'esigenza di conoscere la realtà delle SIC ha promosso uno Studio Nazionale Multicentrico retrospettivo ("SIC 91" ) per valutare i casi di SIC osservati dal 1991 al 2001, avvalendosi inoltre dei dati del Network Italiano "Insufficienza Intestinale in Età Pediatrica". I dati preliminari sono già stati presenatti e pubblicati in altra sede ed hanno permesso di esprimere alcune considerazioni iniziali. Gli obiettivi di questo Studio sono quelli di valutare l'outcome dei pazienti in relaz…

Resezione intestinale massiva Sindrome da Intestino Corto Nutrizione parenterale
researchProduct